-+ 0.00%
-+ 0.00%
-+ 0.00%

Results: Advantest Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Simply Wall St·08/02/2026 00:11:39
Listen to the news

As you might know, Advantest Corporation (TSE:6857) just kicked off its latest quarterly results with some very strong numbers. The company beat forecasts, with revenue of JP¥367b, some 6.8% above estimates, and statutory earnings per share (EPS) coming in at JP¥241, 43% ahead of expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

earnings-and-revenue-growth
TSE:6857 Earnings and Revenue Growth August 2nd 2026

Taking into account the latest results, the consensus forecast from Advantest's 22 analysts is for revenues of JP¥1.63t in 2027. This reflects a major 32% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to bounce 33% to JP¥848. Before this earnings report, the analysts had been forecasting revenues of JP¥1.51t and earnings per share (EPS) of JP¥725 in 2027. So it seems there's been a definite increase in optimism about Advantest's future following the latest results, with a solid gain to the earnings per share forecasts in particular.

View our latest analysis for Advantest

It will come as no surprise to learn that the analysts have increased their price target for Advantest 5.4% to JP¥37,424on the back of these upgrades. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Advantest, with the most bullish analyst valuing it at JP¥45,800 and the most bearish at JP¥23,000 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting Advantest's growth to accelerate, with the forecast 45% annualised growth to the end of 2027 ranking favourably alongside historical growth of 24% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 18% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Advantest is expected to grow much faster than its industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Advantest's earnings potential next year. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

With that in mind, we wouldn't be too quick to come to a conclusion on Advantest. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Advantest going out to 2029, and you can see them free on our platform here..

You should always think about risks though. Case in point, we've spotted 1 warning sign for Advantest you should be aware of.